NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,274,736 | +2.3% | 22,332 | +1.4% | 0.02% | +5.9% |
| Q2 2023 | $2,222,542 | +7.5% | 22,025 | -2.0% | 0.02% | +6.2% |
| Q1 2023 | $2,067,976 | +1.6% | 22,478 | +0.2% | 0.02% | -5.9% |
| Q4 2022 | $2,036,118 | +14.0% | 22,444 | -4.5% | 0.02% | +6.2% |
| Q3 2022 | $1,786,000 | -5.9% | 23,504 | +4.7% | 0.02% | +6.7% |
| Q2 2022 | $1,898,000 | -2.8% | 22,454 | +0.9% | 0.02% | +15.4% |
| Q1 2022 | $1,952,000 | -2.4% | 22,244 | -2.7% | 0.01% | 0.0% |
| Q4 2021 | $2,001,000 | -1.2% | 22,873 | -7.6% | 0.01% | -7.1% |
| Q3 2021 | $2,025,000 | -14.4% | 24,756 | -4.6% | 0.01% | -17.6% |
| Q2 2021 | $2,367,000 | +7.1% | 25,945 | +0.4% | 0.02% | 0.0% |
| Q1 2021 | $2,210,000 | -6.4% | 25,850 | +3.4% | 0.02% | -10.5% |
| Q4 2020 | $2,360,000 | +8.1% | 24,994 | -0.4% | 0.02% | -5.0% |
| Q3 2020 | $2,183,000 | -29.0% | 25,103 | -28.7% | 0.02% | -33.3% |
| Q2 2020 | $3,074,000 | +57.5% | 35,191 | +48.6% | 0.03% | +25.0% |
| Q1 2020 | $1,952,000 | -13.7% | 23,677 | -0.9% | 0.02% | +9.1% |
| Q4 2019 | $2,263,000 | +1.9% | 23,895 | -6.5% | 0.02% | -4.3% |
| Q3 2019 | $2,221,000 | -8.3% | 25,551 | -3.7% | 0.02% | -14.8% |
| Q2 2019 | $2,421,000 | -5.4% | 26,519 | -0.4% | 0.03% | -10.0% |
| Q1 2019 | $2,559,000 | +14.7% | 26,613 | +2.4% | 0.03% | +7.1% |
| Q4 2018 | $2,231,000 | -2.6% | 25,990 | -2.2% | 0.03% | +3.7% |
| Q3 2018 | $2,290,000 | +7.2% | 26,577 | -6.0% | 0.03% | 0.0% |
| Q2 2018 | $2,136,000 | -53.8% | 28,269 | -50.6% | 0.03% | -12.9% |
| Q1 2018 | $4,624,000 | +96.6% | 57,194 | +104.2% | 0.03% | 0.0% |
| Q4 2017 | $2,352,000 | +0.2% | 28,004 | +2.4% | 0.03% | -3.1% |
| Q3 2017 | $2,347,000 | -1.6% | 27,340 | -4.3% | 0.03% | -3.0% |
| Q2 2017 | $2,385,000 | +2.2% | 28,579 | -9.0% | 0.03% | 0.0% |
| Q1 2017 | $2,333,000 | -6.3% | 31,403 | -8.1% | 0.03% | -10.8% |
| Q4 2016 | $2,490,000 | -16.8% | 34,188 | -9.8% | 0.04% | -21.3% |
| Q3 2016 | $2,994,000 | -7.1% | 37,913 | -3.0% | 0.05% | -7.8% |
| Q2 2016 | $3,224,000 | +11.7% | 39,080 | -1.9% | 0.05% | +6.2% |
| Q1 2016 | $2,886,000 | -6.6% | 39,846 | +10.9% | 0.05% | -7.7% |
| Q4 2015 | $3,090,000 | -5.5% | 35,919 | +0.9% | 0.05% | -7.1% |
| Q3 2015 | $3,271,000 | -10.4% | 35,582 | -4.1% | 0.06% | -1.8% |
| Q2 2015 | $3,650,000 | -6.4% | 37,114 | -6.1% | 0.06% | -6.6% |
| Q1 2015 | $3,898,000 | +14.0% | 39,527 | +7.1% | 0.06% | +13.0% |
| Q4 2014 | $3,419,000 | -6.6% | 36,899 | -5.1% | 0.05% | -10.0% |
| Q3 2014 | $3,659,000 | +5.6% | 38,873 | +1.5% | 0.06% | +5.3% |
| Q2 2014 | $3,465,000 | +7.8% | 38,281 | +1.2% | 0.06% | +3.6% |
| Q1 2014 | $3,215,000 | +11.1% | 37,817 | +5.1% | 0.06% | +10.0% |
| Q4 2013 | $2,893,000 | +11.9% | 35,989 | +6.8% | 0.05% | +6.4% |
| Q3 2013 | $2,585,000 | +3.4% | 33,699 | -4.7% | 0.05% | +2.2% |
| Q2 2013 | $2,500,000 | +13.8% | 35,362 | +14.7% | 0.05% | +7.0% |
| Q1 2013 | $2,196,000 | – | 30,830 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |